Skip to content
Disclosery

Oxbow Advisors, LLC: GSK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Oxbow Advisors, LLC on GSK, newest first. How the timeline and the estimate are built.

Oxbow Advisors, LLC held 0 GSK shares at 2026-03-31 per its 13F-HR filed 2026-04-27.

the latest 13F is the newest step

  1. period ended2026-03-31
    13F 0 shares
    Change vs previous 13F -142,798 shares

    13F-HR 0002085853-26-000513 filed by Oxbow Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-12-31
    13F 142,798 shares
    Change vs previous 13F +142,798 shares

    0.62% of the 13F portfolio, value $7,002,814.

    13F-HR 0002085853-26-000196 filed by Oxbow Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-03-31
    13F 0 shares
    Change vs previous 13F -137,172 shares

    13F-HR 0001667731-25-000569 filed by Oxbow Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  4. period ended2024-12-31
    13F 137,172 shares
    Change vs previous 13F -3,563 shares

    0.55% of the 13F portfolio, value $4,639,169.

    13F-HR 0001667731-25-000200 filed by Oxbow Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-09-30
    13F 140,735 shares
    Change vs previous 13F not available

    0.57% of the 13F portfolio, value $5,753,262.

    13F-HR 0001564770-24-000009 filed by Oxbow Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).